160 related articles for article (PubMed ID: 2904706)
1. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
Gerzer R; Karrenbrock B; Siess W; Heim JM
Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of platelet aggregation by endothelium-derived relaxing factor-like agents].
Gerzer R; Karrenbrock B; Drummer C; Heim JM
Med Klin (Munich); 1990 Feb; 85 Suppl 1():18-22. PubMed ID: 2185403
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
6. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
11. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
Severina IS
Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
[TBL] [Abstract][Full Text] [Related]
12. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
13. Increase in activating ability of human platelet guanylate cyclase during aggregation.
Severina IS; Belushkina NN
Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
[TBL] [Abstract][Full Text] [Related]
14. [Relation between human platelet aggregation and activation of soluble platelet guanylate cyclase].
Chirkov IuIu; Tyshchuk IA; Severina IS
Vopr Med Khim; 1990; 36(4):57-60. PubMed ID: 1978441
[TBL] [Abstract][Full Text] [Related]
15. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibition of platelet function by organic nitrates via nitric oxide formation.
Weber AA; Strobach H; Schrör K
Eur J Pharmacol; 1993 Sep; 247(1):29-37. PubMed ID: 8258358
[TBL] [Abstract][Full Text] [Related]
17. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
18. Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.
Karrenbrock B; Heim JM; Gerzer R
Klin Wochenschr; 1990 Feb; 68(4):213-7. PubMed ID: 2156106
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of vasodilation by nitrates: role of cyclic GMP.
Kukovetz WR; Holzmann S; Romanin C
Cardiology; 1987; 74 Suppl 1():12-9. PubMed ID: 2886220
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
Mülsch A; Busse R; Bassenge E
Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
